77 related articles for article (PubMed ID: 19136239)
21. Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.
Foster JM; Aucott L; van der Werf RH; van der Meijden MJ; Schraa G; Postma DS; van der Molen T
Respir Med; 2006 Aug; 100(8):1318-36. PubMed ID: 16442275
[TBL] [Abstract][Full Text] [Related]
22. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
Korsgaard J; Ledet M
Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
[TBL] [Abstract][Full Text] [Related]
23. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
24. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
[TBL] [Abstract][Full Text] [Related]
25. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
Sin DD; Man SF
Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
[TBL] [Abstract][Full Text] [Related]
26. [Long-acting beta-2 agonists. An attempted response to various questions which can be posed by pneumonologists].
Vervloet D; Magnan A
Rev Mal Respir; 1998 Feb; 15(1):25-31. PubMed ID: 9551511
[TBL] [Abstract][Full Text] [Related]
27. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
Wise RA; Tashkin DP
Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
[TBL] [Abstract][Full Text] [Related]
28. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
29. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
Beeh KM; Beier J
Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
[TBL] [Abstract][Full Text] [Related]
30. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
Hui KP
Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
32. [Fixed Combination of a Long-Acting beta(2)-Agonist and an Inhaled Steroid. A Therapeutic Option for COPD?].
Welte T
Med Klin (Munich); 2003 Oct; 98(10):552-61. PubMed ID: 14586509
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.
Ernst P; McIvor A; Ducharme FM; Boulet LP; FitzGerald M; Chapman KR; Bai T;
Ann Intern Med; 2006 Nov; 145(9):692-4. PubMed ID: 17088583
[TBL] [Abstract][Full Text] [Related]
34. Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?
Lipworth BJ; McDevitt DG
Br J Clin Pharmacol; 1992 Feb; 33(2):129-38. PubMed ID: 1347999
[TBL] [Abstract][Full Text] [Related]
35. Present state of the controversy about regular inhaled beta-agonists in asthma.
Giuntini CG; Paggiaro PL
Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
[No Abstract] [Full Text] [Related]
36. [Inhaled combination therapy with corticosteroids and long-acting beta-2 agonists in chronic obstructive pulmonary disease].
Chen YH; Yao WZ; Zhao MW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):928-30. PubMed ID: 19134412
[No Abstract] [Full Text] [Related]
37. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.
Liapikou A; Toumbis M; Torres A
Expert Opin Drug Saf; 2015 Aug; 14(8):1237-47. PubMed ID: 26113207
[TBL] [Abstract][Full Text] [Related]
38. Developments in inhaled combination therapies: patent activity 2013-2014.
Norman P
Expert Opin Ther Pat; 2015; 25(11):1239-45. PubMed ID: 26135360
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of β2-agonists.
Hizawa N
Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
[TBL] [Abstract][Full Text] [Related]
40. Very high dose inhaled corticosteroids: panacea or poison?
Russell G
Arch Dis Child; 2006 Oct; 91(10):802-4. PubMed ID: 16990353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
